Snipr Biome hopes to raise up to USD 80m this year

Gene editing company Snipr Biome wants to boost its capital resources by USD 60-80m before the end of 2022.

Photo: Snipr Biome/PR

Snipr Biome, a gene editing firm based in Denmark, wants to raise USD 60-80m in new capital this year, CEO Christian Grøndahl tells financial daily Børsen.

However, he acknowledges that the current market conditions may be a challenge for the unlisted company, as the equity market has had a very tough year so far.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs